Related Experiment Video
Updated: Jul 5, 2026
07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
The interaction between cholesterol and human serum albumin
Liu Peng1, He Minbo, Chen Fang
1School of Sciences, Wuhan University of Technology, Wuhan 430070, China. chemliup@whut.edu.cn
Protein and Peptide Letters
|May 14, 2008
Summary
Cholesterol binding to Human Serum Albumin (HSA) reduces HSA's fluorescence intensity through static quenching. This enthalpy-driven interaction causes HSA unfolding and decreased hydrophobicity.
Area of Science:
- Biochemistry
- Molecular Biology
- Biophysics
Background:
- Human Serum Albumin (HSA) is a crucial protein in serum, involved in transporting various molecules.
- Cholesterol is a vital lipid, but its dysregulation is linked to various health issues.
- Understanding protein-lipid interactions is key to comprehending physiological and pathological processes.
Purpose of the Study:
- To investigate the molecular interactions between cholesterol and Human Serum Albumin (HSA).
- To elucidate the binding mechanism, thermodynamic parameters, and structural changes induced by cholesterol in HSA.
Main Methods:
- Fluorescence spectroscopy was employed to monitor changes in HSA's intrinsic fluorescence upon cholesterol addition.
- UV-visible (UV-vis) spectroscopy was used to assess structural alterations in HSA.
- Thermodynamic parameters (enthalpy and entropy) were calculated to determine the driving force of the interaction.
Main Results:
- Cholesterol addition led to a decrease in HSA's fluorescence intensity, indicative of static quenching.
- Thermodynamic analysis revealed a negative enthalpy and entropy change, signifying an enthalpy-driven binding process.
- Calculations indicated approximately one binding site per HSA molecule (n = 0.98) with a binding distance of 3.84 nm.
- UV-vis spectra demonstrated partial unfolding of HSA and a reduction in its hydrophobicity in the presence of cholesterol.
Conclusions:
- Cholesterol binds to HSA through an enthalpy-driven mechanism, leading to static quenching of fluorescence.
- The interaction induces conformational changes in HSA, including partial unfolding and decreased hydrophobicity.
- These findings provide insights into the molecular basis of cholesterol transport and its effects on protein structure.
Related Concept Videos
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
01:30Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...